CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

BACKGROUND: Low-molecular-weight heparin (LMWH) is recommended and commonly used for extended treatment of cancer-associated thrombosis (CAT), but its superiority over warfarin has been demonstrated in only one randomised study. We report here the rationale, design and a priori analysis plans of Com...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Agnes YY, Bauersachs, Rupert, Janas, Mette S, Jarner, Mikala F, Kamphuisen, Pieter W, Meyer, Guy, Khorana, Alok A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691586/
https://www.ncbi.nlm.nih.gov/pubmed/23764005
http://dx.doi.org/10.1186/1471-2407-13-284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691586/
https://www.ncbi.nlm.nih.gov/pubmed/23764005
http://dx.doi.org/10.1186/1471-2407-13-284

Ejemplares similares